Clinical Trial Results:
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with ABR-215757 (paquinimod)
Summary
|
|
EudraCT number |
2011-001667-44 |
Trial protocol |
SE DE |
Global completion date |
15 Feb 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
04 Mar 2016
|
First version publication date |
04 Mar 2016
|
Other versions |
|
Summary report(s) |
An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated with Paquinimod (ABR-215757) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.